Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems-Reference-Cited by-同舟云学术

Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems

Published:2016-12 Issue: Volume:136 Page:9-18
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Welch Stephen R.,Guerrero Lisa Wiggleton,Chakrabarti Ayan K.,McMullan Laura K.,Flint Mike,Bluemling Gregory R.,Painter George R.,Nichol Stuart T.,Spiropoulou Christina F.,Albariño César G.

Funder

Oak Ridge Institute for Science and Education

U.S. Department of Energy (DOE)

CDC

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference33 articles.

1. Virus fitness differences observed between two naturally occurring isolates of Ebola virus Makona variant using a reverse genetics approach;Albariño;Virology,2016

2. Development of a reverse genetics system to generate a recombinant Ebola virus Makona expressing a green fluorescent protein;Albariño;Virology,2015

3. Large scale screening and identification of novel Ebolavirus and Marburgvirus entry inhibitors;Anantpadma;Antimicrob. Agents Chemother.,2016

4. A reconstituted replication and transcription system for Ebola virus Reston and comparison with Ebola virus Zaire;Boehmann;Virology,2005

5. Effect of 6-azauridine on de novo pyrimidine biosynthesis in cultured Ehrlich ascites cells. Orotate inhibition of dihydroorotase and dihydroorotate dehydrogenase;Chen;J. Biol. Chem.,1979

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a macrocyclic compound targeting the lassa virus polymerase;Antiviral Research;2024-08

2. Pseudovirus-Based Systems for Screening Natural Antiviral Agents: A Comprehensive Review;International Journal of Molecular Sciences;2024-05-10

3. Treatment of highly virulent mammarenavirus infections—status quo and future directions;Expert Opinion on Drug Discovery;2024-04-12

4. Prevention and post-exposure management of occupational exposure to Ebola virus;The Lancet Infectious Diseases;2024-02

5. Pseudoviruses, a safer toolbox for vaccine development against enveloped viruses;Expert Review of Vaccines;2024-01-03